Case guide

Milk, Formula and NEC: What the Study Can Tell You

Need to understand milk and formula research on NEC? A trial studied some premature babies.

See If You Qualify

Free · No obligation · About 2 minutes

Updated Oct 4, 202617 sources

This may apply to you if

  • Gather the exact formula and feeding history if you have it.
  • Prepare the NEC diagnosis and later care records for legal review.
  • Ask who has authority to act for the child and which law applies.

What the public record says

These are cited sources. Their inclusion does not imply that they endorse People’s Justice or reviewed this page.

Kenneth F. Ripple · United States Court of Appeals for the Seventh Circuit · Circuit Judge, author of the July 2026 opinion

Finding: The five-case opinion reverses federal jurisdiction reasoning and sends the cases back for further proceedings. It does not decide formula causation or personal damages.

Seventh Circuit: Abdullah and related NEC jurisdiction appeals (opens in a new tab) · Jul 28, 2026 · Checked Oct 3, 2026

The evidence and its limits

NICHD Neonatal Research Network, 15 US academic medical centers · JAMA · 2024

MILK trial: donor milk or preterm formula

Design:
Randomized controlled trial
Participants:
483 infants: 239 donor milk, 244 preterm formula
Finding:
Fewer NEC cases with donor milk; no clear difference in developmental scores.
Main limitation
NEC was a secondary outcome. Early closure and varied feeding practices limit interpretation; no individual brand-causation finding.

Read the source: MILK trial: donor milk or preterm formula (opens in a new tab) · Checked Oct 3, 2026

National Advisory Council of Child Health and Human Development working group, NICHD · 2024

NICHD working-group review of NEC science and feeding

Design:
Agency review
Participants:
Not applicable: scientific review and research recommendations, not one patient cohort
Finding:
NEC has many risk factors. Human milk is protective but does not remove all risk; feeding mechanisms remain uncertain.
Main limitation
Evidence often shows association. Small or observational studies and uncertain definitions limit conclusions; this report supplies no clinical-management guidance.

Read the source: NICHD working-group review of NEC science and feeding (opens in a new tab) · Checked Oct 3, 2026

The short answer

What feeds did the trial actually compare?
It compared donor milk with preterm formula. Babies had little or no maternal milk. It did not compare every possible infant diet. [3]
What did the trial find about NEC?
Fewer babies developed NEC in the donor-milk group. NEC was a secondary study outcome. The result does not show that a named product caused one case. [3]
Did developmental outcomes differ clearly?
The later developmental scores did not differ clearly between the groups. That does not decide every baby’s future. Ask the team about the child’s own follow-up. [3]
What can this tell us about fortifiers?
The base diet was the trial comparison. Bovine fortifiers were used. Do not treat it as a trial comparing every type of fortifier. [3]

What rules a case out

Not covered by this case

  • No feeding plan is prescribed here.
  • Donor milk and maternal milk are not the same trial comparison.
  • A base-diet comparison does not decide all fortifier or brand questions.

The process

What happens next

  1. 01

    You answer a few questions

    About two minutes. Nothing is sent until you agree on the last step and press submit.

  2. 02

    A lawyer looks at it

    A lawyer at the firm reads your answers and checks them against the current case criteria.

  3. 03

    The firm decides and gets in touch

    If the firm takes your case, you get the terms in writing to read before you sign. You can always say no.

Need to understand milk and formula research on NEC? A trial studied some premature babies. Ask the care team what feed fits your baby. The study does not give a personal care plan.

What feeds did the trial actually compare?

It compared donor milk with preterm formula. Babies had little or no maternal milk. It did not compare every possible infant diet.

Colaizy’s randomized trial enrolled 483 extremely preterm infants at fifteen US academic centers. The comparison had 239 donor-milk and 244 formula infants. These study rules do not determine the right feeding plan for a particular baby.

What did the trial find about NEC?

Fewer babies developed NEC in the donor-milk group. NEC was a secondary study outcome. The result does not show that a named product caused one case.

The original paper reports ten NEC cases with donor milk and twenty-two with formula. Early closure and varied feeding practices limit the interpretation. Keep the studied groups and outcome separate from a claim about every formula user.

Did developmental outcomes differ clearly?

The later developmental scores did not differ clearly between the groups. That does not decide every baby’s future. Ask the team about the child’s own follow-up.

The study assessed development at 22–26 months of corrected age, which accounts for early birth. A group comparison at that point cannot promise a lifetime outcome or rule out lasting harm in a particular NEC survivor. The clinical record has its own role.

What can this tell us about fortifiers?

The base diet was the trial comparison. Bovine fortifiers were used. Do not treat it as a trial comparing every type of fortifier.

NICHD separately discusses fortification evidence and uncertain nutrition questions. Product type, amount and timing need to be identified from the actual feeding record. A broad brand label cannot supply those details.

What if maternal or donor milk is not available?

Ask the clinical team about feasible nutrition for the baby. A parent may not be able to supply enough milk. No feed choice should be changed from this page.

The NICHD review identifies milk access and feeding questions that need more research. Human milk is protective but does not remove all NEC risk. Its research recommendations are not a personal clinical plan or guarantee that donor milk is available.

How should a family use the evidence in a claim check?

Keep the exact feeds, care dates and diagnosis. Ask a lawyer what the study can support for your facts. Get personal time limits and written fees checked separately.

A comparison of research groups does not establish a hospital’s or manufacturer’s legal responsibility. Request covered records through the proper representative process, and confirm who receives them. A legal inquiry is not a filed claim.

Find out where you stand.

The review is free and private. Asking for it doesn’t commit you to anything.

Register your interest

Sources

  1. Seventh Circuit: Abdullah and related NEC jurisdiction appealsSeventh Circuit: Abdullah and related NEC jurisdiction appeals · court
  2. Northern District of Illinois: MDL3026 public case pageNorthern District of Illinois: MDL3026 public case page · court
  3. Colaizy et al.: donor milk or preterm formula randomized trialColaizy et al.: donor milk or preterm formula randomized trial · study
  4. NICHD: NEC working group report, September16,2024NICHD: NEC working group report, September16,2024 · regulator
  5. MedlinePlus: necrotizing enterocolitisMedlinePlus: necrotizing enterocolitis · regulator
  6. FDA: infant formula information for parents and caregiversFDA: infant formula information for parents and caregivers · regulator
  7. HHS: personal representatives and children’s recordsHHS: personal representatives and children’s records · regulator
  8. HHS: Your Medical RecordsHHS: Your Medical Records · regulator
  9. ABA Model Rule1.5: feesABA Model Rule1.5: fees
  10. SDNY: how long to file a complaintSDNY: how long to file a complaint · court
  11. U.S. Courts: civil casesU.S. Courts: civil cases · court
  12. Seventh Circuit: judges of the courtSeventh Circuit: judges of the court · court
  13. Collins v. Mead Johnson (Missouri state court, St. Louis): jury returned a full defense verdict for Mead Johnson in an NEC trial brought by Cadence Collins over her daughter's NEC after Enfamil Premature 24 — decided on specific causation, less than three weeks after the Watson reversal. No damages awarded. Verified via CityAM report of the July 2, 2026 verdict quoting the company statement.cityam.com · Jul 2, 2026
  14. Watson $60M verdict REVERSED: Appellate Court of Illinois, Fifth District (2026 IL App (5th) 240936, filed 06/12/26) reversed and remanded for a new trial. Panel held the trial court erred on the learned-intermediary doctrine (duty to warn runs to physicians, not the mother) and admitted excessive evidence of Mead Johnson's finances, tainting the trial. Verified directly from the appellate opinion PDF (court record via CourtListener).storage.courtlistener.com · Jun 12, 2026
  15. Gill $495M verdict UPHELD: Missouri appellate court on May 6, 2026 affirmed the full $495 million award ($95M compensatory / $400M punitive) against Abbott, calling Abbott's conduct 'significantly reprehensible' and finding it failed to warn consumers or change formula ingredients. Abbott said it strongly disagrees and will seek further appellate review (Missouri Supreme Court). Verified via wire story on Yahoo Finance; the appeals court subsequently declined to transfer the case to the Missouri Supreme Court (June 2026, per search results — transfer denial not independently fetch-verified).finance.yahoo.com · May 6, 2026 · court
  16. Gill v. Abbott (St. Louis, MO state court): jury (9 of 12) awarded $495 million — $95M compensatory + $400M punitive — to Margo Gill, whose daughter Robynn developed NEC after being fed Abbott's cow's-milk-based preterm Similac formula at Cardinal Glennon Children's Hospital following premature birth in 2021. Largest NEC formula verdict to date. Verified via First Alert 4 (KMOV St. Louis) local press.firstalert4.com · Jul 26, 2024
  17. Watson v. Mead Johnson (St. Clair County, IL Circuit Court, No. 21-L-1032): unanimous jury awarded Jasmine Watson $60 million on strict-liability failure-to-warn and negligence claims over the NEC death of premature infant Chance Dean fed Enfamil Premature 24 — first NEC formula trial verdict in the nation. Verdict amount and claims independently confirmed by the Illinois appellate opinion (2026 IL App (5th) 240936). Date per plaintiff-firm Keller Postman announcement (law-firm source — flagged; amount court-record-confirmed).kellerpostman.com · Mar 14, 2024

Checked against 13 primary sources by People's Justice editors · Updated

How we make money

People's Justice research team · Updated Oct 4, 2026